Mereo BioPharma Group plc (MAH0) — Strategic Asset Allocation Index
Mereo BioPharma Group plc (MAH0) has a Strategic Asset Allocation Index of 2.7% as of June 2023. Strategic assets (PP&E of €1.56 Million plus long-term investments of €-) total €1.56 Million, measured against net assets of €57.74 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check MAH0 financial resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Mereo BioPharma Group plc Strategic Asset Allocation Index (2016–2022)
This chart shows how Mereo BioPharma Group plc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2022. As of June 2023, the index stands at 2.7%, representing strategic assets of €1.56 Million against net assets of €57.74 Million EUR. See MAH0 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Mereo BioPharma Group plc (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Mereo BioPharma Group plc from 2016 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Mereo BioPharma Group plc (MAH0) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.0% | €1.83 Million | €1.83 Million | €- | €61.87 Million | ▲ +0.1 pp |
| 2021 | 2.9% | €2.53 Million | €2.53 Million | €- | €88.00 Million | ▼ -25.8 pp |
| 2019 | 28.7% | €11.56 Million | €11.56 Million | €- | €40.26 Million | ▲ +28.3 pp |
| 2018 | 0.5% | €149.00K | €149.00K | €- | €32.77 Million | ▲ +0.2 pp |
| 2017 | 0.2% | €153.36K | €153.36K | €- | €62.48 Million | ▲ +0.0 pp |
| 2016 | 0.2% | €173.87K | €173.87K | €- | €79.26 Million | — |